Market Place
Sourcing Support
TerSera Presents Goserelin Real-World Data At 2024 SABCS Symposium
12 Dec 2024 //
BUSINESSWIRE
TerSera Presents Goserelin Data At ASCO Quality Care Symposium
02 Oct 2024 //
BUSINESSWIRE
TerSera Canada’s goserelin acetate receives` ER+ early breast cancer canada
09 May 2024 //
PHARMABIZ
Health Canada Approves ZOLADEX For ER+ Breast Cancer Management
07 May 2024 //
BUSINESSWIRE
AZ hit with fine in Korea over plot to stall generic of lucrative cancer med
14 Oct 2022 //
FIERCEPHARMA
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Nov 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
AstraZeneca cuts 94 jobs from UK campus
27 Mar 2019 //
IN-PHARMATECHNOLOGIST
AstraZeneca sells 3 drugs for $350M upfront
11 Mar 2019 //
BIOPHARMADIVE
Astra`s Soriot Says Slow Pace of Brexit Talks an Area of Concern
06 Sep 2017 //
BLOOMBERG
AstraZeneca to invest £150m in new facility
05 Sep 2017 //
THE MANUFACTURE
AZ confirms Macclesfield plan but says “wait to see” Brexit strategy unchanged
29 Aug 2017 //
IN PHARMATECHNOLOGIST
AstraZeneca sells off cancer drug to TerSera for $250 million
21 Feb 2017 //
PHARMAFILE
AstraZeneca Opens Cancer Med Plant in UK
21 Dec 2016 //
FIERCE PHARMA
Alvogen launches first generic equivalent of Zoladex
09 May 2016 //
CPHI ONLINE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.